1、Wong TY, Cheung CMG, Larsen M, et al. Diabetic retinopathy[ J]. Nat
Rev Dis Primers, 2016, 2: 16012.Wong TY, Cheung CMG, Larsen M, et al. Diabetic retinopathy[ J]. Nat
Rev Dis Primers, 2016, 2: 16012.
2、中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2017年
版)[ J]. 中国实用内科杂志, 2018, 38(4): 292-344.
Chinese Diabetes Society. Guidelines for the prevention and control
of type 2 diabetes in China (2017 Edition)[ J]. Chinese Journal of
Practical Internal Medicine, 2018, 38(4): 292-344.中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2017年
版)[ J]. 中国实用内科杂志, 2018, 38(4): 292-344.
Chinese Diabetes Society. Guidelines for the prevention and control
of type 2 diabetes in China (2017 Edition)[ J]. Chinese Journal of
Practical Internal Medicine, 2018, 38(4): 292-344.
3、Chen H, Zhang X, Shen X. Ocular changes during hemodialysis in
patients with end-stage renal disease[ J]. BMC Ophthalmol, 2018,
18(1): 208.Chen H, Zhang X, Shen X. Ocular changes during hemodialysis in
patients with end-stage renal disease[ J]. BMC Ophthalmol, 2018,
18(1): 208.
4、Zhang J, Wang Y, Li L, et al. Diabetic retinopathy may predict the renal
outcomes of patients with diabetic nephropathy[ J]. Ren Fail, 2018,
40(1): 243-251.Zhang J, Wang Y, Li L, et al. Diabetic retinopathy may predict the renal
outcomes of patients with diabetic nephropathy[ J]. Ren Fail, 2018,
40(1): 243-251.
5、Hung CC, Lin HYH, Hwang DY, et al. Diabetic retinopathy and clinical
parameters favoring the presence of diabetic nephropathy could predict
renal outcome in patients with diabetic kidney disease[ J]. Sci Rep,
2017, 7(1): 1236.Hung CC, Lin HYH, Hwang DY, et al. Diabetic retinopathy and clinical
parameters favoring the presence of diabetic nephropathy could predict
renal outcome in patients with diabetic kidney disease[ J]. Sci Rep,
2017, 7(1): 1236.
6、Romero-Aroca P, Baget-Bernaldiz M, Navarro-Gil R, et al. Glomerular
filtration rate and/or ratio of urine albumin to creatinine as markers
for diabetic retinopathy: a ten-year follow-up study[ J]. J Diabetes Res,
2018, 2018: 5637130.Romero-Aroca P, Baget-Bernaldiz M, Navarro-Gil R, et al. Glomerular
filtration rate and/or ratio of urine albumin to creatinine as markers
for diabetic retinopathy: a ten-year follow-up study[ J]. J Diabetes Res,
2018, 2018: 5637130.
7、El-Menyar A, Al Thani H, Hussein A, et al. Diabetic retinopathy: a new
predictor in patients on regular hemodialysis[ J]. Curr Med Res Opin,
2012, 28(6): 999-1055.El-Menyar A, Al Thani H, Hussein A, et al. Diabetic retinopathy: a new
predictor in patients on regular hemodialysis[ J]. Curr Med Res Opin,
2012, 28(6): 999-1055.
8、Jamal S, Ali MH, Ayub MH, et al. Frequency and grading of diabetic
retinopathy in diabetic end stage renal disease patients[ J]. Pakistan
Journal of Ophthalmology, 2016, 32(2): 64-69.Jamal S, Ali MH, Ayub MH, et al. Frequency and grading of diabetic
retinopathy in diabetic end stage renal disease patients[ J]. Pakistan
Journal of Ophthalmology, 2016, 32(2): 64-69.
9、Tan GS, Cheung N, Simo R, et al. Diabetic macular oedema[ J]. Lancet
Diabetes Endocrinol, 2017, 5(2): 143-155.Tan GS, Cheung N, Simo R, et al. Diabetic macular oedema[ J]. Lancet
Diabetes Endocrinol, 2017, 5(2): 143-155.
10、Tokuyama T, Ikeda T, Sato K. Effects of haemodialysis on diabetic
macular leakage[ J]. Br J Ophthalmol, 2000, 84(12): 1397-1400.Tokuyama T, Ikeda T, Sato K. Effects of haemodialysis on diabetic
macular leakage[ J]. Br J Ophthalmol, 2000, 84(12): 1397-1400.
11、Matsuo T. Disappearance of diabetic macular hard exudates after
hemodialysis introduction[J]. Acta Med Okayama, 2006, 60(3): 201-205.Matsuo T. Disappearance of diabetic macular hard exudates after
hemodialysis introduction[J]. Acta Med Okayama, 2006, 60(3): 201-205.
12、Ong SS, Thomas AS, Fekrat S. Improvement of recalcitrant diabetic
macular edema after peritoneal dialysis[ J]. Ophthalmic Surg Lasers
Imaging Retina, 2017, 48(10): 834-837.Ong SS, Thomas AS, Fekrat S. Improvement of recalcitrant diabetic
macular edema after peritoneal dialysis[ J]. Ophthalmic Surg Lasers
Imaging Retina, 2017, 48(10): 834-837.
13、Hwang H, Chae JB, Kim JY, et al. Changes in optical coherence
tomography findings in patients with chronic renal failure undergoing
dialysis for the first time[ J]. Retina, 2019, 39(12): 2360-2368.Hwang H, Chae JB, Kim JY, et al. Changes in optical coherence
tomography findings in patients with chronic renal failure undergoing
dialysis for the first time[ J]. Retina, 2019, 39(12): 2360-2368.
14、Jung JW, Yoon MH, Lee SW, et al. Effect of hemodialysis (HD) on
intraocular pressure, ocular surface, and macular change in patients
with chronic renal failure[ J]. Graefes Arch Clin Exp Ophthalmol, 2013,
251(1): 153-162.Jung JW, Yoon MH, Lee SW, et al. Effect of hemodialysis (HD) on
intraocular pressure, ocular surface, and macular change in patients
with chronic renal failure[ J]. Graefes Arch Clin Exp Ophthalmol, 2013,
251(1): 153-162.
15、Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/
ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for
the prevention, detection, evaluation, and management of high blood
pressure in adults: a report of the American College of Cardiology/
American Heart Association Task Force on Clinical Practice
Guidelines[ J]. J Am Coll Cardiol, 2018, 71(19): e127-e248.Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/
ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for
the prevention, detection, evaluation, and management of high blood
pressure in adults: a report of the American College of Cardiology/
American Heart Association Task Force on Clinical Practice
Guidelines[ J]. J Am Coll Cardiol, 2018, 71(19): e127-e248.
16、Muntner P, Anderson A, Charleston J, et al. Hypertension awareness,
treatment, and control in adults with CKD: results from the Chronic
Renal Insufficiency Cohort (CRIC) Study[ J]. Am J Kidney Dis, 2010,
55(3): 441-451.Muntner P, Anderson A, Charleston J, et al. Hypertension awareness,
treatment, and control in adults with CKD: results from the Chronic
Renal Insufficiency Cohort (CRIC) Study[ J]. Am J Kidney Dis, 2010,
55(3): 441-451.
17、Do DV, Wang X, Vedula SS, et al. Blood pressure control for diabetic
retinopathy[ J]. Cochrane Database Syst Rev, 2015, 1: CD006127.Do DV, Wang X, Vedula SS, et al. Blood pressure control for diabetic
retinopathy[ J]. Cochrane Database Syst Rev, 2015, 1: CD006127.
18、Leypoldt JK, Cheung AK, Delmez JA, et al. Relationship between
volume status and blood pressure during chronic hemodialysis[ J].
Kidney Int, 2002, 61(1): 266-275.Leypoldt JK, Cheung AK, Delmez JA, et al. Relationship between
volume status and blood pressure during chronic hemodialysis[ J].
Kidney Int, 2002, 61(1): 266-275.
19、Bakris GL, Burkart JM, Weinhandl ED, et al. Intensive hemodialysis,
blood pressure, and antihypertensive medication use[ J]. Am J Kidney
Dis, 2016, 68: S15-S23.Bakris GL, Burkart JM, Weinhandl ED, et al. Intensive hemodialysis,
blood pressure, and antihypertensive medication use[ J]. Am J Kidney
Dis, 2016, 68: S15-S23.
20、Xu J, Chen LJ, Yu J, et al. Involvement of advanced glycation end
products in the pathogenesis of diabetic retinopathy[ J]. Cell Physiol
Biochem, 2018, 48(2): 705-717.Xu J, Chen LJ, Yu J, et al. Involvement of advanced glycation end
products in the pathogenesis of diabetic retinopathy[ J]. Cell Physiol
Biochem, 2018, 48(2): 705-717.
21、Yamagishi SI, Nakamura N, Suematsu M, et al. Advanced glycation end
products: a molecular target for vascular complications in diabetes[ J].
Mol Med, 2015, 21(Suppl 1): S32-S40.Yamagishi SI, Nakamura N, Suematsu M, et al. Advanced glycation end
products: a molecular target for vascular complications in diabetes[ J].
Mol Med, 2015, 21(Suppl 1): S32-S40.
22、Cornelis T, Eloot S, Vanholder R, et al. Protein-bound uraemic toxins,
dicarbonyl stress and advanced glycation end products in conventional
and extended haemodialysis and haemodiafiltration[ J]. Nephrol Dial
Transplant, 2015, 30(8): 1395-1402.
Cornelis T, Eloot S, Vanholder R, et al. Protein-bound uraemic toxins,
dicarbonyl stress and advanced glycation end products in conventional
and extended haemodialysis and haemodiafiltration[ J]. Nephrol Dial
Transplant, 2015, 30(8): 1395-1402.
23、Sies H, Berndt C, Jones DP. Oxidative stress[ J]. Annu Rev Biochem,
2017, 86(1): 715-748.Sies H, Berndt C, Jones DP. Oxidative stress[ J]. Annu Rev Biochem,
2017, 86(1): 715-748.
24、Calderon G, Juarez O, Hernandez G, et al. Oxidative stress and diabetic
retinopathy: development and treatment[ J]. Eye, 2017, 31(8): 1122.Calderon G, Juarez O, Hernandez G, et al. Oxidative stress and diabetic
retinopathy: development and treatment[ J]. Eye, 2017, 31(8): 1122.
25、Li C, Miao X, Li F, et al. Oxidative stress-related mechanisms and
antioxidant therapy in diabetic retinopathy[ J]. Oxid Med Cell Longev,
2017, 2017: 9702820.Li C, Miao X, Li F, et al. Oxidative stress-related mechanisms and
antioxidant therapy in diabetic retinopathy[ J]. Oxid Med Cell Longev,
2017, 2017: 9702820.
26、Witko-Sarsat V, Friedlander M, Capeillère-Blandin C, et al. Advanced
oxidation protein products as a novel marker of oxidative stress in
uremia[ J]. Kidney Int, 1996, 49(5): 1304-1313.Witko-Sarsat V, Friedlander M, Capeillère-Blandin C, et al. Advanced
oxidation protein products as a novel marker of oxidative stress in
uremia[ J]. Kidney Int, 1996, 49(5): 1304-1313.
27、Liakopoulos V, Roumeliotis S, Gorny X, et al. Oxidative stress in
hemodialysis patients: a review of the literature[ J]. Oxid Med Cell
Longev, 2017, 2017: 3081856.Liakopoulos V, Roumeliotis S, Gorny X, et al. Oxidative stress in
hemodialysis patients: a review of the literature[ J]. Oxid Med Cell
Longev, 2017, 2017: 3081856.
28、Boaz M, Smetana S, Weinstein T, et al. Secondary prevention with
antioxidants of cardiovascular disease in endstage renal disease
(SPACE): randomised placebo-controlled trial[ J]. Lancet, 2000,
356(9237): 1213-1218.Boaz M, Smetana S, Weinstein T, et al. Secondary prevention with
antioxidants of cardiovascular disease in endstage renal disease
(SPACE): randomised placebo-controlled trial[ J]. Lancet, 2000,
356(9237): 1213-1218.
29、Mahaffey KW, Granger CB, Toth CA, et al. Diabetic retinopathy should
not be a contraindication to thrombolytic therapy for acute myocardial
infarction: review of ocular hemorrhage incidence and location in the
GUSTO-I trial[ J]. J Am Coll Cardiol, 1997, 30(7): 1606-1610.Mahaffey KW, Granger CB, Toth CA, et al. Diabetic retinopathy should
not be a contraindication to thrombolytic therapy for acute myocardial
infarction: review of ocular hemorrhage incidence and location in the
GUSTO-I trial[ J]. J Am Coll Cardiol, 1997, 30(7): 1606-1610.
30、Tolwani A, Wille KM. Advances in continuous renal replacement
therapy: citrate anticoagulation update[ J]. Blood Purif, 2012, 34(2):
88-93.Tolwani A, Wille KM. Advances in continuous renal replacement
therapy: citrate anticoagulation update[ J]. Blood Purif, 2012, 34(2):
88-93.
31、Stem MS, Gardner TW. Neurodegeneration in the pathogenesis
of diabetic retinopathy: molecular mechanisms and therapeutic
implications[ J]. Curr Med Chem, 2013, 20(26): 3241-3250.Stem MS, Gardner TW. Neurodegeneration in the pathogenesis
of diabetic retinopathy: molecular mechanisms and therapeutic
implications[ J]. Curr Med Chem, 2013, 20(26): 3241-3250.
32、Hayreh SS. Ischemic optic neuropathy[ J]. Prog Retin Eye Res, 2009,
28(1): 34-62.
Hayreh SS. Ischemic optic neuropathy[ J]. Prog Retin Eye Res, 2009,
28(1): 34-62.
33、Maio T, Lemos J, Moreira J, et al. Visual impairment after
haemodialysis[ J]. Neuroophthalmology, 2019, 43(1): 43-48.Maio T, Lemos J, Moreira J, et al. Visual impairment after
haemodialysis[ J]. Neuroophthalmology, 2019, 43(1): 43-48.
34、Shemesh A, Margolin E. Sequential nonarteritic anterior ischemic optic
neuropathy in patient on chronic hemodialysis[ J]. CEN Case Rep,
2019, 8(2): 89-94.Shemesh A, Margolin E. Sequential nonarteritic anterior ischemic optic
neuropathy in patient on chronic hemodialysis[ J]. CEN Case Rep,
2019, 8(2): 89-94.
35、Al Zubidi N, Zhang J, Spitze A, et al. Pallid disc edema and choroidal
perfusion delay in posthemodialysis nonarteritic ischemic optic
neuropathy[ J]. Can J Ophthalmol, 2013, 48(5): e120-e123.Al Zubidi N, Zhang J, Spitze A, et al. Pallid disc edema and choroidal
perfusion delay in posthemodialysis nonarteritic ischemic optic
neuropathy[ J]. Can J Ophthalmol, 2013, 48(5): e120-e123.
